Weak antioxidant. Antimutagenic. Stimulates bone formation and has potential activity against osteoporosis. Shows inhibitory activities against the antigen-induced degranulation and weak estrogen-like activity.
Product Specification
| Identity: | Determined by 1H-NMR, 13C-NMR and MS. |
| |
| Formula: | C20H20O4 |
| |
| MW: | 324.4 |
| |
| Purity: | ≥97% (HPLC) |
| |
| Appearance: | Yellow solid. |
| |
| CAS: | 19879-32-4 |
| |
| Source/Host: | Isolated from plant Psoralea corylifolia. |
| |
| Solubility: | Soluble in DMSO or 100% ethanol. |
| |
| Long Term Storage: | -20°C |
| |
| Handling: | Protect from light. |
| |
Please mouse over
Product Literature References
Bioactive constituents from Chinese natural medicines. XX. Inhibitors of antigen-induced degranulation in RBL-2H3 cells from the seeds of Psoralea corylifolia: H. Matsuda, et al.; Chem. Pharm. Bull. (Tokyo)
55, 106 (2007),
Abstract;
Synthesis of four natural prenylflavonoids and their estrogen-like activities: X. Dong, et al.; Arch. Pharm. (Weinheim)
340, 372 (2007),
Abstract;
Antioxidative components of Psoralea corylifolia (Leguminosae): H. Haraguchi, et al.; Phytother. Res.
16, 539 (2002),
Abstract;
Osteoblastic proliferation stimulating activity of Psoralea corylifolia extracts and two of its flavonoids: D. Wang, et al.; Planta Med.
67, 748 (2001),
Abstract;
Antiplatelet flavonoids from seeds of Psoralea corylifolia: W.J. Tsai, et al.; J. Nat. Prod.
59, 671 (1996),
Abstract;